Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernhard Spitzer

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|February 23, 2017
Predictive factors for functional improvement following intravitreal bevacizumab injections after central retinal vein occlusionGesine B Szurman, Carsten H Meyer, Nicolas Feltgen, et al.
Acta Ophthalmologica|February 3, 2016
Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicentre studyGesine B Szurman, Kai Januschowski, Peter Szurman, et al.
Acta Ophthalmologica|January 27, 2015
Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicenter studyKai Januschowski, Spyridon Dimopoulos, Peter Szurman, et al.
Plos One|May 30, 2018
Intravenous thrombolysis in acute central retinal artery occlusion - A prospective interventional case seriesMaximilian Schultheiss, Florian Härtig, Martin S Spitzer, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|February 23, 2017
Predictive factors for functional improvement following intravitreal bevacizumab injections after central retinal vein occlusionGesine B Szurman, Carsten H Meyer, Nicolas Feltgen, et al.
Acta Ophthalmologica|February 3, 2016
Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicentre studyGesine B Szurman, Kai Januschowski, Peter Szurman, et al.
Acta Ophthalmologica|January 27, 2015
Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicenter studyKai Januschowski, Spyridon Dimopoulos, Peter Szurman, et al.
Plos One|May 30, 2018
Intravenous thrombolysis in acute central retinal artery occlusion - A prospective interventional case seriesMaximilian Schultheiss, Florian Härtig, Martin S Spitzer, et al.
Pageof 6